Malcolm Brenner, an internationally recognized physician‑scientist renowned for his leadership in cell and gene therapy, has ...

The University of Oklahoma has received an $11.5 million award from the National Institutes of Health to establish the ...

A molecular geneticist at Montana State University has discovered a cellular process once believed impossible by scientists – ...

Announcing a new article publication for Zoonoses journal. Tuberculosis (TB) is among the main infectious diseases ...

In the split second after you hear a noise, your brain is already making a potentially life-or-death deduction: Did I do that ...

For many people who suffer from depression, the condition is not just about feeling down, but also about a loss of motivation ...

Researchers from NYU Abu Dhabi, in collaboration with Cleveland Clinic Abu Dhabi, have developed a tiny, injectable medical ...

A recent study by Ruibao Li and Jennah Dharamshi published in Nature may help us understand the beginnings of animal ...

Primary hyperparathyroidism (PHPT) is a common endocrine disorder characterized by excessive secretion of parathyroid hormone ...

The U.S. Food and Drug Administration (FDA) has approved pembrolizumab, an immunotherapy, plus belzutifan, a HIF-2α inhibitor, as adjuvant treatment for adult patients with renal cell carcinoma with a ...

Researchers at Kanazawa University have identified a previously unrecognized mechanism by which structural changes in the ...

Researchers at the Federal University of São Paulo (UNIFESP) in Brazil have discovered a new strategy that may protect ...